3D Tissue Models
SciBX Summit on Innovation in Drug Discovery and Development 2013
The Colonnade Hotel
120 Huntington Ave
Boston, Massachusetts
The 2013 SciBX Summit on Innovation in Drug Discovery and Development brings together key stakeholders from academia, biotech, pharma and the investment community to create a roadmap for solving key translational issues in important emerging areas of drug discovery and development. This year's summit will focus on four areas where recent progress is rapidly changing the translational playing field: non-coding RNAs, chimeric antigen receptor-based cell therapies, new models in neurodegenerative disease and emerging targets in epigenetics.

Schedule of Presentations:

Tuesday, October 29, 2013
07:15:00 Welcome Reception
16:00:00 Summit Registration Opens
18:15:00 Welcome Remarks Karen Bernstein
18:30:00 Keynote Presentation : Shifting Scales: The Transition from Chemistry to Biology, and from Biology to the Clinic
Wednesday, October 30, 2013
08:00:00 Registration and Continental Breakfast
09:00:00 Session I Concurrent Topics
09:05:00 No n - coding RNAs as tools and targets David Corey, Jean-Francois Formela, John Maraganore
10:00:00 New models in neurological disease Daniela Brunner, Mustafa Sahin
12:00:00 L u n c h
14:00:00 Session II : Concurrent Topics
14:30:00 CAR - based cellular therapies Stewart Abbot, Gwendolyn Binder-Scholl, Renier J. Brentjens
15:30:00 Epigenetics Second wind Peter J Tummino
17:30:00 Closing Reception
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.